Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Apr 24, 2025

Keywords

ClinConnect Summary

This clinical trial aims to understand how the care of patients with cirrhosis, a serious liver condition, has improved in intensive care units (ICUs) over the past decade. Researchers will look at how changes in treatment practices from 2014 to 2024 have affected the outcomes for these patients, including their chances of recovery and access to liver transplants. They will also explore how different hospitals may care for these patients differently based on their resources and facilities.

To participate in this study, individuals must be over 18 years old and diagnosed with cirrhosis, either through a liver specialist's assessment or medical testing. There are no specific exclusions, meaning anyone who meets these criteria could potentially join the study. Participants can expect their experiences and outcomes in the ICU to be closely examined, helping to shape future treatment for cirrhosis patients. This study is important because it aims to improve care and support for patients with this challenging condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with cirrhosis over 18 years of age (cirrhosis either histologically proven or diagnosed by hepatologists according to clinical, biological and ultrasound criteria) admitted to intensive care between January 2014 and December 2024.
• Exclusion Criteria:
• • None